penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin
2021-SR-545
Phase 2 small_molecule active
Quick answer
penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin for Lymphoma, Large B-Cell, Diffuse is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Lymphoma, Large B-Cell, Diffuse
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active